Are American adults capable of quarantining?
If you think quarantine needs a better publicist in the United States, you might be right.
New Zealanders went into a strict lockdown and so did Italians. So did the residents of China, Spain, Bolivia, Morocco and South Korea.
The idea of isolating for a stretch of two weeks either because you’ve been exposed to Covid-19 or are traveling from a Covid-19 hotspot, however, can feel like a punishment to Americans, not a long-standing infectious disease prevention policy.
It might feel the same way to thousands of Germans: Demonstrators gathered near Berlin’s Brandenburg Gate Wednesday to protest an ongoing nationwide lockdown, Berlin police spokesman Stefan Petersen earlier told CNN. When the crowds didn’t disperse, police used water cannons to move protestors away from the area, Berlin police said.
December 18, 2020
An unplanned interim analysis from a study that was halted in the aftermath of concerns about paclitaxel shows no difference in rates of long-term all-cause mortality between patients with PAD treated with coated or uncoated devices, regardless of the extent of limb disease.
The SWEDEPAD trialists, along with those from the BASIL-3 study, paused recruitment following publication of a meta-analysis in late 2018 by Konstantinos Katsanos, MD, PhD (Patras University Hospital, Rion, Greece), and colleagues. The controversial meta-analysis reported a 68% relative increase in risk of all-cause death with paclitaxel-coated devices versus uncoated devices at 2 years and a 93% relative risk increase by 5 years in those with femoral and/or popliteal artery disease.
Dec 17, 2020
The annual meeting of the San Antonio Breast Cancer Symposium was held virtually this year from Dec. 8 to 11 and attracted participants from around the world, including medical oncologists, radiation oncologists, researchers, and other health care professionals. The conference highlighted recent advances in the risk, diagnosis, treatment, and prevention of breast cancer, with presentations focusing on emerging treatments in hard-to-treat patient populations, including patients with metastatic breast cancer.
As part of the RxPONDER study, Kevin Kalinsky, M.D., of the Glenn Family Breast Center at the Winship Cancer Institute of Emory University in Atlanta, and colleagues found that postmenopausal women with lymph node-positive early-stage breast cancer and a low recurrence score receive no additional benefit from chemotherapy.
email article
The idea that old vaccines might have a role in the fight against COVID-19 has been floated since the early days of the pandemic. Vaccines stimulate the broad, innate immune response, which appears to play a key role in fighting COVID-19. Can the approach bridge the time until entire populations are vaccinated specifically against SARS-CoV-2?
Three vaccines dominate the discussion: bacillus Calmette-Guérin (BCG) against tuberculosis; measles, mumps, and rubella (MMR); and oral polio vaccine (OPV).
BCG has been associated with milder courses of infection for respiratory syncytial virus, human papillomavirus, herpes simplex, and influenza. Fifteen clinical trials are testing it for COVID-19, but a drawback is the 1% rate of adverse events.